# Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous Integrated Boost for Early-Stage Breast Cancer (H-ASSIST)

> **NCT06902311** · PHASE2 · RECRUITING · sponsor: **UNC Lineberger Comprehensive Cancer Center** · enrollment: 90 (estimated)

## Conditions studied

- Breast Cancer
- Early-stage Breast Cancer
- Ductal Carcinoma in Situ
- DCIS

## Interventions

- **RADIATION:** Breast Radiotherapy

## Key facts

- **NCT ID:** NCT06902311
- **Lead sponsor:** UNC Lineberger Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-19
- **Primary completion:** 2028-02
- **Final completion:** 2028-02
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2026-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06902311

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06902311, "Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous Integrated Boost for Early-Stage Breast Cancer (H-ASSIST)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06902311. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*